JUVENTAS
Live / Allowed — Fourth extension granted (statement of use) (as of 11 Jun 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 08 Mar 2023 filing date already counts against anyone who files later.
Record
- Serial number
- 97829720
- Mark type
- Word mark
- Filed
- 08 Mar 2023
- Published for opposition
- 16 Apr 2024
- Attorney of record
- Yong Chen
Goods and services
- Class 042 — Scientific and technological services: Providing services in preparing cells product, namely, development of cells product, including chimeric antigen receptor T Cells, NK cells, DC cells, based on cells harvested from patients, for providing such cell products to hospitals, clinics or other organizations or entities involved in delivering healthcare services to patients
Owner
- JUVENTAS CELL THERAPY LTD., Beijing, CN
- JUVENTAS CELL THERAPY LTD., Beijing, CN
Prosecution history
- 12 Jun 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Jun 2026 — SOU EXTENSION 4 GRANTED
- 11 Jun 2026 — SOU EXTENSION 4 FILED
- 11 Jun 2026 — SOU TEAS EXTENSION RECEIVED
- 10 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Dec 2025 — SOU EXTENSION 3 GRANTED
- 09 Dec 2025 — SOU EXTENSION 3 FILED
- 09 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Jun 2025 — SOU EXTENSION 2 GRANTED
- 03 Jun 2025 — SOU EXTENSION 2 FILED
- 03 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 08 Dec 2024 — SOU EXTENSION 1 GRANTED
- 08 Dec 2024 — SOU EXTENSION 1 FILED
- 07 Dec 2024 — SOU TEAS EXTENSION RECEIVED